These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12100017)
1. Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge. Ahmed RK; Makitalo B; Karlen K; Nilsson C; Biberfeld G; Thorstensson R Clin Exp Immunol; 2002 Jul; 129(1):11-8. PubMed ID: 12100017 [TBL] [Abstract][Full Text] [Related]
2. Role of CD8+ cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge. Ahmed RK; Nilsson C; Biberfeld G; Thorstensson R Scand J Immunol; 2001 Mar; 53(3):245-53. PubMed ID: 11251881 [TBL] [Abstract][Full Text] [Related]
3. Secretion of beta-chemokines by bronchoalveolar lavage cells during primary infection of macaques inoculated with attenuated nef-deleted or pathogenic simian immunodeficiency virus strain mac251. Caufour P; Le Grand R; Ch Ret A; Neildez O; Th Odoro F; Boson B; Vaslin B; Dormont D J Gen Virol; 1999 Mar; 80 ( Pt 3)():767-776. PubMed ID: 10092018 [TBL] [Abstract][Full Text] [Related]
4. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Gauduin MC; Glickman RL; Ahmad S; Yilma T; Johnson RP Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14031-6. PubMed ID: 10570193 [TBL] [Abstract][Full Text] [Related]
5. Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge. Ahmed RK; Nilsson C; Wang Y; Lehner T; Biberfeld G; Thorstensson R J Gen Virol; 1999 Jul; 80 ( Pt 7)():1569-1574. PubMed ID: 10423123 [TBL] [Abstract][Full Text] [Related]
6. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867 [TBL] [Abstract][Full Text] [Related]
7. A genetically engineered live-attenuated simian-human immunodeficiency virus that co-expresses the RANTES gene improves the magnitude of cellular immunity in rhesus macaques. Shimizu Y; Inaba K; Kaneyasu K; Ibuki K; Himeno A; Okoba M; Goto Y; Hayami M; Miura T; Haga T Virology; 2007 Apr; 361(1):68-79. PubMed ID: 17157892 [TBL] [Abstract][Full Text] [Related]
8. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV. Gauduin MC; Glickman RL; Means R; Johnson RP J Virol; 1998 Aug; 72(8):6315-24. PubMed ID: 9658070 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques. Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675 [TBL] [Abstract][Full Text] [Related]
11. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336 [TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys. Kaneyasu K; Kita M; Ohkura S; Yamamoto T; Ibuki K; Enose Y; Sato A; Kodama M; Miura T; Hayami M Microbiol Immunol; 2005; 49(12):1083-94. PubMed ID: 16365534 [TBL] [Abstract][Full Text] [Related]
13. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116 [TBL] [Abstract][Full Text] [Related]
14. Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys. Walther-Jallow L; Nilsson C; Söderlund J; Ten Haaft P; Mäkitalo B; Biberfeld P; Böttiger P; Heeney J; Biberfeld G; Thorstensson R J Gen Virol; 2001 Jul; 82(Pt 7):1601-1612. PubMed ID: 11413371 [TBL] [Abstract][Full Text] [Related]
15. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum. LaFranco-Scheuch L; Abel K; Makori N; Rothaeusler K; Miller CJ J Virol; 2004 Jun; 78(12):6399-408. PubMed ID: 15163733 [TBL] [Abstract][Full Text] [Related]
16. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316 [TBL] [Abstract][Full Text] [Related]
17. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization. Biberfield G; Putkonen P; Thorstensson R; Norrby E AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992 [TBL] [Abstract][Full Text] [Related]
18. Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge. Harandi AM; Svennerholm B; Holmgren J; Eriksson K Am J Reprod Immunol; 2001 Dec; 46(6):420-4. PubMed ID: 11775012 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif. Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171 [TBL] [Abstract][Full Text] [Related]
20. Simian/human immunodeficiency virus(89.6) expressing the chemokine genes MIP-1alpha, RANTES, or lymphotactin. Waterman PM; Kitabwalla M; Tikhonov I; Pauza CD Viral Immunol; 2003; 16(1):35-44. PubMed ID: 12725687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]